MedPath

HUMULIN 30/70 (INSULIN HUMAN BIOSYNTH INJ)

HUMULIN 30/70 (INSULIN HUMAN BIOSYNTH INJ)

Approved
DIN Number

00795879

Drug Class

Human

Market Date

Dec 31, 1989

Company
HC

eli lilly canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00795879
AIG Number0220670002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
A10AD01 INSULIN (HUMAN)
Product Specifications
Dosage FormSuspension
Route of AdministrationSubcutaneous
AHFS Classification68:20.08
Health Canada Classification

ACTIVE INGREDIENTS (2)

INSULINActive
Strength: 30 UNIT / ML
Monograph: INSULIN
INSULIN ISOPHANE (NPH)Active
Strength: 70 UNIT / ML
Monograph: INSULIN ISOPHANE (NPH)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.